These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38813321)

  • 21. The Cancer Cachexia Index Can Be Used to Prognostically Predict Patients with Gastric Cancer Undergoing Gastrectomy.
    Sakurai K; Kubo N; Hasegawa T; Nishimura J; Iseki Y; Nishii T; Inoue T; Yashiro M; Nishiguchi Y; Maeda K
    Ann Nutr Metab; 2023; 79(6):511-521. PubMed ID: 37751717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cachexia Index in Advanced Non-Small-Cell Lung Cancer Patients.
    Jafri SH; Previgliano C; Khandelwal K; Shi R
    Clin Med Insights Oncol; 2015; 9():87-93. PubMed ID: 26604850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cachexia index as a prognostic predictor after resection of pancreatic ductal adenocarcinoma.
    Shimagaki T; Sugimachi K; Mano Y; Onishi E; Iguchi T; Nakashima Y; Sugiyama M; Yamamoto M; Morita M; Toh Y
    Ann Gastroenterol Surg; 2023 Nov; 7(6):977-986. PubMed ID: 37927935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Frailty Grade Combined with Cachexia Index and Osteopenia in Esophagectomy.
    Takahashi K; Masuda T; Ishikawa Y; Tanishima Y; Kurogochi T; Yuda M; Tanaka Y; Matsumoto A; Yano F; Eto K
    World J Surg; 2023 Jun; 47(6):1503-1511. PubMed ID: 36802232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic impact of perioperative dynamic changes in cachexia index in patients with hepatocellular carcinoma.
    Akaoka M; Haruki K; Yamahata Y; Okazaki K; Furukawa K; Tsunematsu M; Shirai Y; Onda S; Matsumoto M; Ikegami T
    Ann Gastroenterol Surg; 2024 Sep; 8(5):917-926. PubMed ID: 39229565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significant impact of cachexia index on the outcomes after hepatic resection for colorectal liver metastases.
    Tanji Y; Furukawa K; Haruki K; Taniai T; Onda S; Tsunematsu M; Shirai Y; Yanagaki M; Igarashi Y; Ikegami T
    Ann Gastroenterol Surg; 2022 Nov; 6(6):804-812. PubMed ID: 36338593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
    Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer.
    Demirelli B; Babacan NA; Ercelep Ö; Öztürk MA; Kaya S; Tanrıkulu E; Khalil S; Hasanov R; Alan Ö; Telli TA; Koca S; Arıbal ME; Kuzan B; Dane F; Yumuk PF
    Nutr Cancer; 2021; 73(2):230-238. PubMed ID: 32270713
    [No Abstract]   [Full Text] [Related]  

  • 29. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study.
    Kasahara K; Enomoto M; Udo R; Tago T; Mazaki J; Ishizaki T; Yamada T; Nagakawa Y; Katsumata K; Tsuchida A
    BMC Cancer; 2022 Jan; 22(1):20. PubMed ID: 34980009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of platelet-to-lymphocyte ratıo (PLR) and glasgow prognostıc score (GPS) on recurrence, and survıval ın patıents undergoıng lobectomy for early-stage non-small cell lung cancer (NSCLC).
    Agaoglu Sanli B; Gulmez B; Yazgan S; Ucvet A
    Updates Surg; 2024 Apr; 76(2):631-639. PubMed ID: 37853294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
    Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammation-based scoring is a useful prognostic predictor of pulmonary resection for elderly patients with clinical stage I non-small-cell lung cancer.
    Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kunizaki M; Taniguchi D; Nagayasu T
    Eur J Cardiothorac Surg; 2015 Apr; 47(4):e140-5. PubMed ID: 25548132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.
    Imai H; Kishikawa T; Minemura H; Yamada Y; Ibe T; Yamaguchi O; Mouri A; Hamamoto Y; Kanazawa K; Kasai T; Kaira K; Kaburagi T; Minato K; Kobayashi K; Kagamu H
    Cancer Med; 2021 Oct; 10(20):6971-6984. PubMed ID: 34414673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glasgow prognostic score is a better predictor of the long-term survival in patients with gastric cancer, compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score.
    Hirahara N; Matsubara T; Kaji S; Kawabata Y; Hyakudomi R; Yamamoto T; Uchida Y; Ishitobi K; Takai K; Tajima Y
    Oncotarget; 2020 Nov; 11(45):4169-4177. PubMed ID: 33227100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of cachexia on outcomes in aggressive lymphomas.
    Karmali R; Alrifai T; Fughhi IAM; Ng R; Chukkapalli V; Shah P; Basu S; Nathan S; Szymanski-Grant K; Gordon LI; Venugopal P; Penedo FJ; Borgia JA
    Ann Hematol; 2017 Jun; 96(6):951-956. PubMed ID: 28417157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-Reactive Protein-based Prognostic Measures Are Superior at Predicting Survival Compared with Peripheral Blood Cell Count-based Ones in Patients After Curative Resection for Pancreatic Cancer.
    Fujiwara Y; Haruki K; Shiba H; Hamura R; Horiuchi T; Shirai Y; Furukawa K; Gocho T; Yanaga K
    Anticancer Res; 2018 Nov; 38(11):6491-6499. PubMed ID: 30396977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical utility of pretreatment Glasgow prognostic score in non-small-cell lung cancer patients treated with immune checkpoint inhibitors.
    Takamori S; Takada K; Shimokawa M; Matsubara T; Fujishita T; Ito K; Toyozawa R; Yamaguchi M; Okamoto T; Yoneshima Y; Tanaka K; Okamoto I; Tagawa T; Mori M
    Lung Cancer; 2021 Feb; 152():27-33. PubMed ID: 33341085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The inflammation-based Glasgow Prognostic Score predicts survival in patients with cervical cancer.
    Polterauer S; Grimm C; Seebacher V; Rahhal J; Tempfer C; Reinthaller A; Hefler L
    Int J Gynecol Cancer; 2010 Aug; 20(6):1052-7. PubMed ID: 20683416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the Glasgow Prognostic Score in patients receiving chemoradiotherapy for stage III and IV esophageal cancer.
    Kimura J; Kunisaki C; Makino H; Oshima T; Ota M; Oba M; Takagawa R; Kosaka T; Ono HA; Akiyama H; Endo I
    Dis Esophagus; 2016 Nov; 29(8):1071-1080. PubMed ID: 26471766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.